NVO vs MEDP
Novo Nordisk A/S vs Medpace — AI-powered side-by-side comparison
| Metric | NVO | MEDP |
|---|---|---|
| AI Score | 51 | 62 |
| Price | $47.08 | $577.05 |
| P/E Ratio | 11.17× | 33.19× |
| ROE | 0.5% | 1.0% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 0.3% |
| Debt / Equity | 0.72× | 0.28× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 33.8 | 58.0 |
| Beta | 0.36 | 1.151 |
| Expected Upside | +1.4% | +8.0% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NVO Full Analysis
MEDP Full Analysis